These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
483 related articles for article (PubMed ID: 11114293)
41. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway. Yue J; Mulder KM J Biol Chem; 2000 Oct; 275(40):30765-73. PubMed ID: 10843986 [TBL] [Abstract][Full Text] [Related]
42. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. Dennler S; Itoh S; Vivien D; ten Dijke P; Huet S; Gauthier JM EMBO J; 1998 Jun; 17(11):3091-100. PubMed ID: 9606191 [TBL] [Abstract][Full Text] [Related]
43. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Yingling JM; Datto MB; Wong C; Frederick JP; Liberati NT; Wang XF Mol Cell Biol; 1997 Dec; 17(12):7019-28. PubMed ID: 9372933 [TBL] [Abstract][Full Text] [Related]
44. TGF-beta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Hayashida T; Poncelet AC; Hubchak SC; Schnaper HW Kidney Int; 1999 Nov; 56(5):1710-20. PubMed ID: 10571779 [TBL] [Abstract][Full Text] [Related]
45. Transcriptional regulation of tristetraprolin by transforming growth factor-beta in human T cells. Ogawa K; Chen F; Kim YJ; Chen Y J Biol Chem; 2003 Aug; 278(32):30373-81. PubMed ID: 12754205 [TBL] [Abstract][Full Text] [Related]
46. Smad3 and Smad4 mediate transforming growth factor-beta1-induced IgA expression in murine B lymphocytes. Park SR; Lee JH; Kim PH Eur J Immunol; 2001 Jun; 31(6):1706-15. PubMed ID: 11385614 [TBL] [Abstract][Full Text] [Related]
47. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283 [TBL] [Abstract][Full Text] [Related]
49. Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts. Ihn H; Yamane K; Asano Y; Jinnin M; Tamaki K Rheumatology (Oxford); 2006 Feb; 45(2):157-65. PubMed ID: 16319104 [TBL] [Abstract][Full Text] [Related]
50. Potentiation of Smad transactivation by Jun proteins during a combined treatment with epidermal growth factor and transforming growth factor-beta in rat hepatocytes. role of phosphatidylinositol 3-kinase-induced AP-1 activation. Peron P; Rahmani M; Zagar Y; Durand-Schneider AM; Lardeux B; Bernuau D J Biol Chem; 2001 Mar; 276(13):10524-31. PubMed ID: 11134003 [TBL] [Abstract][Full Text] [Related]
51. Transforming growth factor-beta-induced transcription of the Alzheimer beta-amyloid precursor protein gene involves interaction between the CTCF-complex and Smads. Burton T; Liang B; Dibrov A; Amara F Biochem Biophys Res Commun; 2002 Jul; 295(3):713-23. PubMed ID: 12099698 [TBL] [Abstract][Full Text] [Related]
52. Beta-hydroxybutyrate-induced growth inhibition and collagen production in HK-2 cells are dependent on TGF-beta and Smad3. Guh JY; Chuang TD; Chen HC; Hung WC; Lai YH; Shin SJ; Chuang LY Kidney Int; 2003 Dec; 64(6):2041-51. PubMed ID: 14633126 [TBL] [Abstract][Full Text] [Related]
53. Poly(ADP-ribose) polymerase 1 is indispensable for transforming growth factor-β Induced Smad3 activation in vascular smooth muscle cell. Huang D; Wang Y; Wang L; Zhang F; Deng S; Wang R; Zhang Y; Huang K PLoS One; 2011; 6(10):e27123. PubMed ID: 22073128 [TBL] [Abstract][Full Text] [Related]
54. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling. Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129 [TBL] [Abstract][Full Text] [Related]
55. Cell type-specific regulation of the TGF-beta-responsive alpha2(I) collagen gene by CpG methylation. Yamane K; Suzuki H; Ihn H; Kato M; Yoshikawa H; Tamaki K J Cell Physiol; 2005 Mar; 202(3):822-30. PubMed ID: 15389632 [TBL] [Abstract][Full Text] [Related]
56. Blockade of the effects of TGF-beta1 on mesangial cells by overexpression of Smad7. Chen R; Huang C; Morinelli TA; Trojanowska M; Paul RV J Am Soc Nephrol; 2002 Apr; 13(4):887-893. PubMed ID: 11912247 [TBL] [Abstract][Full Text] [Related]
57. Structural and functional characterization of the transforming growth factor-beta -induced Smad3/c-Jun transcriptional cooperativity. Qing J; Zhang Y; Derynck R J Biol Chem; 2000 Dec; 275(49):38802-12. PubMed ID: 10995748 [TBL] [Abstract][Full Text] [Related]
58. The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3. Chipuk JE; Cornelius SC; Pultz NJ; Jorgensen JS; Bonham MJ; Kim SJ; Danielpour D J Biol Chem; 2002 Jan; 277(2):1240-8. PubMed ID: 11707452 [TBL] [Abstract][Full Text] [Related]
59. Smad proteins regulate transcriptional induction of the SM22alpha gene by TGF-beta. Chen S; Kulik M; Lechleider RJ Nucleic Acids Res; 2003 Feb; 31(4):1302-10. PubMed ID: 12582250 [TBL] [Abstract][Full Text] [Related]
60. Transforming growth factor-beta1 up-regulation of human alpha(1)(I) collagen is mediated by Sp1 and Smad2 transacting factors. Sysa P; Potter JJ; Liu X; Mezey E DNA Cell Biol; 2009 Sep; 28(9):425-34. PubMed ID: 19558215 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]